Skip to content
DraconiticResearch
Search Sources API
194,226 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BYThe Egyptian Journal of Histology

The Potential Role of Curcumin Nanoparticles on the Cuprizone Model of Multiple Sclerosis in Mice. Is Remyelination Possible?

4 affiliations
  1. 1Anatomy and Embryology Department Faculty of Medicine, Alexandria University, Alexandria, Egypt
  2. 2Professor of Neurology, Department of Neuropsychiatry, Faculty of Medicine. Alexandria University, Alexandria, Egypt
  3. 3Associate Professor of Neuropsychiatry, Department of Neuropsychiatry, Faculty of Medicine. Alexandria University, Alexandria, Egypt
  4. 4Lecturer of Pathology, Department of Pathology, Faculty of Medicine. Alexandria University, Alexandria, Egypt

Abstract

Introduction: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that primarily affects myelin, leading progressively to disability and neurological dysfunction. Current pharmacological therapies are able only to alleviate symptoms or delay disease progression but fail to stop the pathogenic degeneration. Recently, curcumin nanoparticles (CurNPs) have attracted attention due to their antioxidant and anti-inflammatory properties, suggesting a potential therapeutic role in neurodegenerative disorders.Aim of the Work: The present study aimed to evaluate the histological changes induced by cuprizone-mediated demyelination in the white matter of mice brains and to explore the potential protective and reparative role of CurNPs in this toxic model.Materials and Methods: Thirty-six adult female black mice were randomly divided into four equal groups (n= 9): control (cuprizone-free diet), cuprizone-fed, acute phase, and chronic phase of motor and behavioral alterations. Neurological and behavioral tests, including rotarod, open field, and passive avoidance, were performed at the fourth and sixth weeks to assess motor performance and long-term memory. Subsequently, detailed histopathological assessment of the brains was conducted.Results: Histological examination in the demyelination group revealed severe loss of myelin within the corpus callosum, while CurNPs-treated groups exhibited remyelinated fibers and evidence of repair. Groups III and IV displayed significantly reduced inflammation and demyelination scores (P<0.05), with group III lower than group IV. Six weeks of cuprizone feeding induced pronounced motor deficits and impaired memory, whereas CurNPs treatment improved both parameters. Biochemically, cuprizone increased MDA levels and reduced SOD activity, while CurNPs markedly enhanced SOD activity compared with the demyelination group.Conclusion: This study demonstrated a significant bioactive role of CurNPs in the cuprizone-induced MS model in mice. CurNPs improved behavioral outcomes, reduced demyelination, and modulated oxidative stress. These findings support CurNPs as a promising therapeutic approach in neurodegenerative diseases, emphasizing the need for further studies to clarify mechanisms and long-term efficacy.

Related

  1. Why repair fails in AQP4-IgG-positive neuromyelitis optica spectrum disease: an astrocyte-centered framework for remyelination and neuroaxonal preservation
    Wenjing Luo, Ni Peng, Siqian Wei +3
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  2. CD300f is required for efficient lipid handling during cuprizone-induced demyelination
    G. Manich, N. Rego, E. de Frutos +7
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  3. Hierarchical control of remyelination by heparan sulfate sulfation
    R. Muthaiah, R. Ravichandar, R. Poddeti +7
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  4. Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design
    Jörg Distler, Shervin Assassi, Armando Gabrielli +33
    Annals of the Rheumatic DiseasesPeer-reviewedCC BY 4.0Full textImmunologyHAL
  5. Constructing co-assembly derived smart lipid nanoparticles for enhanced antimicrobial potency with plant growth-promoting potential
    Jia-Rui Rao, Lei Liu, Zhi-Jun Luo +8
    Journal of NanobiotechnologyPeer-reviewedCC BY-NC-ND 4.0Full text2 citedPlant biologyPMC
BibTeX
@article{ahmed2026potential,
  title = {{The Potential Role of Curcumin Nanoparticles on the Cuprizone Model of Multiple Sclerosis in Mice. Is Remyelination Possible?}},
  author = {Abeer Ahmed and Mohamed Boraey and Jaidaa Mekky and Samar Achy},
  journal = {The Egyptian Journal of Histology},
  year = {2026},
  month = sep,
  doi = {10.21608/ejh.2025.415262.2313},
  url = {https://doi.org/10.21608/ejh.2025.415262.2313},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The Potential Role of Curcumin Nanoparticles on the Cuprizone Model of Multiple Sclerosis in Mice. Is Remyelination Possible?
AU  - Abeer Ahmed
AU  - Mohamed Boraey
AU  - Jaidaa Mekky
AU  - Samar Achy
PY  - 2026
DA  - 2026/09/01
JO  - The Egyptian Journal of Histology
DO  - 10.21608/ejh.2025.415262.2313
UR  - https://doi.org/10.21608/ejh.2025.415262.2313
AB  - Introduction: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that primarily affects myelin, leading progressively to disability and neurological dysfunction. Current pharmacological therapies are able only to alleviate symptoms or delay disease progression but fail to stop the pathogenic degeneration. Recently, curcumin nanoparticles (CurNPs) have attracted attention due to their antioxidant and anti-inflammatory properties, suggesting a potential therapeutic role in neurodegenerative disorders.Aim of the Work: The present study aimed to evaluate the histological changes induced by cuprizone-mediated demyelination in the white matter of mice brains and to explore the potential protective and reparative role of CurNPs in this toxic model.Materials and Methods: Thirty-six adult female black mice were randomly divided into four equal groups (n= 9): control (cuprizone-free diet), cuprizone-fed, acute phase, and chronic phase of motor and behavioral alterations. Neurological and behavioral tests, including rotarod, open field, and passive avoidance, were performed at the fourth and sixth weeks to assess motor performance and long-term memory. Subsequently, detailed histopathological assessment of the brains was conducted.Results: Histological examination in the demyelination group revealed severe loss of myelin within the corpus callosum, while CurNPs-treated groups exhibited remyelinated fibers and evidence of repair. Groups III and IV displayed significantly reduced inflammation and demyelination scores (P<0.05), with group III lower than group IV. Six weeks of cuprizone feeding induced pronounced motor deficits and impaired memory, whereas CurNPs treatment improved both parameters. Biochemically, cuprizone increased MDA levels and reduced SOD activity, while CurNPs markedly enhanced SOD activity compared with the demyelination group.Conclusion: This study demonstrated a significant bioactive role of CurNPs in the cuprizone-induced MS model in mice. CurNPs improved behavioral outcomes, reduced demyelination, and modulated oxidative stress. These findings support CurNPs as a promising therapeutic approach in neurodegenerative diseases, emphasizing the need for further studies to clarify mechanisms and long-term efficacy.
SN  - 2090-2417
SN  - 1110-0559
ER  -